Evaluation of Minimal Residual Disease (MRD) Negativity in Patients with Relapsed or Refractory Multiple Myeloma Treated in the Candor Study
Year: 2020
Type: article
Source: Blood
Authors: Ola Landgren, Katja Weisel, Laura Rosinol Dachs, Philippe Moreau, Mehmet Turgut, Roman Hajek, Peter Mollee, Jin Seok Kim, Jianqi Zhang, Ning Go, Christopher L. Morris, Saad Z. Usmani
Institutions: Memorial Sloan Kettering Cancer Center, University Medical Center Hamburg-Eppendorf, Hospital Clínic de Barcelona, Centre Hospitalier Universitaire de Nantes, Ondokuz Mayıs University, University Hospital Ostrava, Princess Alexandra Hospital, Yonsei University, Severance Hospital, Amgen (United States)
Language: English
Subfield: Hematology
Field: Medicine
Domain: Health Sciences
Open Access status: closed
OpenAlex ID: W3097226579